Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

BCR Corporation (AKA: BCR Diagnostics)
Profile last edited on: 10/1/19      CAGE: 3NZE6      UEI:

Business Identifier: Sterility Testing and Biosensor for Bacteria Detection
Year Founded
1994
First Award
1994
Latest Award
2013
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

145 South 79th Street Suite 13
Chandler, AZ 85226
   (480) 809-6158
   info@bcrbiotech.com
   www.bcrbiotech.com
Location: Single
Congr. District: 09
County: Maricopa

Public Profile

Formerly located in Rhode Island until early 2011, BCR Corporation (BCR) had pioneered the use of fluorogenic substrates to study enzymes and cellular membrane function. Other BCR products include diagnostic tests for enumerating tumor cells in blood and bone marrow.

Extent of SBIR involvement

User Avatar
Phase I Awards
5
Phase II Awards
2
Conversion Rate
40.00%
Phase I Dollars
$561,347
Phase II Dollars
$1,438,226
Total Awarded
$1,999,573

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
10-14

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2013 1 NIH $145,637
Project Title: Ultrasensitive Detection of Hepatitis Viruses by Immunoassay Amplification
2009 2 NIH $778,950
Project Title: Engineered Spores as Fluorogenic Biological Indicators for Sterility Testing
2004 1 NIH $137,221
Project Title: Low-Cost Biosensor for Real-Time Diagnosis of Bacteremia
2004 2 NIH $875,429
Project Title: Real-Time Detection of Bacteria in Platelet Concentrates
1994 1 NIH $62,336
Project Title: Test for occult micrometastases in primary breast cancer

Key People / Management

  M Boris Rotman -- President

Company News

There are no news available.